Novo Nordisk Income from Continuous Operations 2010-2024 | NVO

Novo Nordisk income from continuous operations for the twelve months ending June 30, 2024 was $13.050B, a 37.24% increase year-over-year.

  • Novo Nordisk annual income from continuous operations for 2023 was $12.151B, a 54.54% increase from 2022.
  • Novo Nordisk annual income from continuous operations for 2022 was $7.862B, a 3.48% increase from 2021.
  • Novo Nordisk annual income from continuous operations for 2021 was $7.598B, a 17.7% increase from 2020.

Novo Nordisk Income from Continuous Operations 2010-2024 | NVO

  • Novo Nordisk annual income from continuous operations for 2023 was $12.151B, a 54.54% increase from 2022.
  • Novo Nordisk annual income from continuous operations for 2022 was $7.862B, a 3.48% increase from 2021.
  • Novo Nordisk annual income from continuous operations for 2021 was $7.598B, a 17.7% increase from 2020.